Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Mental Health

Date Submitted: Apr 16, 2021
Open Peer Review Period: Apr 16, 2021 - Jun 11, 2021
Date Accepted: Jun 7, 2021
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Virtual Reality for Supporting the Treatment of Depression and Anxiety: Scoping Review

Baghaei N, Chitale V, Hlasnik A, Stemmet L, Liang HN, Porter R

Virtual Reality for Supporting the Treatment of Depression and Anxiety: Scoping Review

JMIR Ment Health 2021;8(9):e29681

DOI: 10.2196/29681

PMID: 34554097

PMCID: 8498902

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Virtual Reality for Supporting Depression and Anxiety: A Scoping Review

  • Nilufar Baghaei; 
  • Vibhav Chitale; 
  • Andrej Hlasnik; 
  • Lehan Stemmet; 
  • Hai-Ning Liang; 
  • Richard Porter

ABSTRACT

Background:

Mental health conditions pose a major challenge to healthcare providers and society at large. The World Health Organization (WHO) predicts that by 2030, mental health conditions will be the leading disease burden globally. The current need for mental health care is overwhelming. In New Zealand, one in six adults have been diagnosed with common mental disorders such as depression, and anxiety disorders according to a national survey. Cognitive behavioral therapy (CBT) has been shown to effectively help patients overcome a wide variety of mental health conditions. Virtual Reality Exposure Therapy (VRET) might be one of the most exciting technology that is emerging in the clinical setting for the treatment of anxiety and depression.

Objective:

This study aimed to investigate what VR technologies are currently being used to help suppress depression and anxiety. Primarily we identified whether the CBT was included as part of the virtual reality exposure therapy treatment (VRET), and if so, how? Equally important, the focus was set not only on VR hardware and used software tools but also on what the participants did in the virtual environment and how the virtual environment looked like

Methods:

We performed a scoping review. To identify significant studies, we decided to use already aggregated sources in Google Scholar Database. Overall, the goal of our search strategy was to limit the number of initial results related to virtual reality in mental health to only a relevant minimum.

Results:

Using our defined key words, Google Scholar identified more than 17300 articles. After applying all inclusion and exclusion criteria, we identified a total of 369 articles for further processing. After manual evaluation, 34 articles were shortlisted, of which 9 reported the usage of CBT with VR. All these articles were published between 2017 and 2021.

Conclusions:

Majority of the studies demonstrated the use of VR to be effective for suppressing anxiety or depression in a range of settings and recommended its potential as tool for usage in a clinical environment. As standalone headsets are much easier to work with and more suitable for home usage, the shift from tethered VR headsets to standalone headsets in the mental health environment was not observed. A total of 9 studies explicitly mentioned the usage of CBT. Out of these, CBT was conducted within a virtual reality environment in 5 studies while in the remaining 4 studies CBT was used as an addition to VRET. All 9 studies reported the use of CBT either in vivo or inside a virtual environment to be effective in suppressing anxiety or depression.


 Citation

Please cite as:

Baghaei N, Chitale V, Hlasnik A, Stemmet L, Liang HN, Porter R

Virtual Reality for Supporting the Treatment of Depression and Anxiety: Scoping Review

JMIR Ment Health 2021;8(9):e29681

DOI: 10.2196/29681

PMID: 34554097

PMCID: 8498902

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.